What is Insomnia Therapeutics Market?
Insomnia is a sleep disorder in which the person has difficulty sleeping or sleeping. Symptoms are low stamina, daytime sleepiness, depression, and irritability. It is a common disease affecting millions of people around the world. Insomnia-related disorders are caused by disorders of the circadian rhythm, chronic pain, hyperthyroidism, menopause, psychological stress, and other disorders. In addition, excessive consumption of drugs like caffeine, alcohol, and nicotine can lead to insomnia. This disorder can be diagnosed in sleep laboratories with a variety of diagnostic equipment. Depending upon the duration of the disorder, insomnia is thereby divided into three types, namely transient, acute and chronic insomnia. In transient insomnia, symptoms persist for a few days to a few weeks; acute insomnia lasts for several weeks and chronic insomnia lasts for months to several years.
The market study is being classified by Type (Pharmacological Treatments [Prescription Sleep Aids, Over-the-Counter Sleep Aids] and Non-pharmacological Treatments), by Application (Clinics and Hospitals) and major geographies with country level break-up.
Eisai, Co. Ltd. (Japan), Merck & Co., Inc. (United States), Mylan N.V. (United States), Meda Consumer Healthcare Inc. (United States), Eli Lilly and Company (United States), Pfizer, Inc. (United States), Sanofi (France), Takeda Pharmaceutical Company Ltd. (Japan), Pernix Therapeutics (United States), Sumitomo Dainippon Pharma Co., Ltd. (Japan), ECR Pharmaceuticals (United States), Purdue Pharma L.P. (United States) and Vanda Pharmaceuticals, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Ebb Therapeutics (United States), Fidia Farmaceutici (Italy) and Paratek Pharmaceuticals Inc. (United States).
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Insomnia Therapeutics market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Insomnia Therapeutics market by Type, Application and Region.
On the basis of geography, the market of Insomnia Therapeutics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Prevalence of Insomnia across the World
- Rising Stress Level
- A Rise in Shift-Work Sleep Disorder and Increased Stress Level
- Growing Geriatric Population
- Increasing Awareness about Various Treatment Options
- Growing Awareness about the Advantages of Melatonin and Valerian Roots
- The Emergence of Newer Therapeutics with Lesser Adverse Effects
- The Rise in Constantly Improving Healthcare Reimbursement Policies
- A Paradigm Shift Due To Rising Awareness among Patients
- Prolonged Use of These Drugs May Lead To Resistance
- Growing Demand for Sleep Disorder Treatment in the Emerging Economies
- High Healthcare Spending
- Development of New Technologies and Introduction of Medical Devices
- Higher Adoption of Generic Products That Are Available In Cheaper Price
Key Target AudienceProviders of Insomnia Therapeutics, Potential Investors, Market Research Firms, Regulatory Bodies, End-Users and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase